You are here

P&T® Journal contents for September 2002


New treatments for irritable bowel syndrome, erectile dysfunction, and postherpetic neuralgia
Marvin M. Goldenberg, PhD
The author discusses the effects of various drugs on the cardiac QTc interval.
Alan Hopefl, PharmD
Cover Story
The increasing use of complementary and alternative remedies presents a challenge to pharmacists as they strive to ensure rational drug therapy.
Kenneth R. Cohen, PhD, RPh, Peter Cerone, MS, RPh, and Robert Ruggiero, PharmD
The authors evaluated the budget impact of risedronate and alendronate in the treatment of patients with postmenopausal osteoporosis.
D. T. Grima, MSc, R. T. Burge, PhD, D. L. Becker, MSc, and A. N. A. Tosteson, ScD
Continuing Education
The authors review vaccines included on the recommended childhood immuzation schedule that are currently in short supply and propose suggestions for tracking patients affected by vaccine shortages.
S. Jay Weaver, PharmD, and Paul L. Doering, MS Pharm
Guest Commentary
In an effort to inform and safeguard the growing number of consumers who use dietary supplements, the U.S. Pharmacopeia (USP) has developed the Dietary Supplement Verification Program.
Miriam Reisman


Editor-in-Chief David Nash discusses “Prophylactic Ethics” in the age of genomics.
David B. Nash, MD, MBA
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
Medication Errors
Matthew Grissinger, RPh, discusses savings that can result from implementing CPOE systems.
Matthew Grissinger
Prescription Washington
DHHS sets marketing hurdle for PBMs.
Stephen Barlas